Form 8-K - Current report:
SEC Accession No. 0001104659-21-082678
Filing Date
2021-06-17
Accepted
2021-06-17 16:57:53
Documents
17
Period of Report
2021-06-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2119593d4_8k.htm   iXBRL 8-K 31960
2 EXHIBIT 1.1 tm2119593d4_ex1-1.htm EX-1.1 311904
3 EXHIBIT 5.1 tm2119593d4_ex5-1.htm EX-5.1 5941
4 GRAPHIC tm2119593d4_ex5-1img001.jpg GRAPHIC 3043
5 GRAPHIC tm2119593d4_ex5-1img002.jpg GRAPHIC 5012
6 GRAPHIC tm2119593d4_ex5-1img003.jpg GRAPHIC 8286
  Complete submission text file 0001104659-21-082678.txt   626032

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20210615.xsd EX-101.SCH 3208
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20210615_lab.xml EX-101.LAB 34592
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20210615_pre.xml EX-101.PRE 22725
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2119593d4_8k_htm.xml XML 3858
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 211025488
SIC: 2834 Pharmaceutical Preparations